Mathieu Levesque

Learn More
Somatic activation of the KRAS proto-oncogene is evident in almost all pancreatic cancers, and appears to represent an initiating event. These mutations occur primarily at codon 12 and less frequently at codons 13 and 61. Although some studies have suggested that different KRAS mutations may have variable oncogenic properties, to date there has been no(More)
of blastemal cells and up-regulating genes important for an effective regeneration progress. Some candidate molecules have been suggested to play the role of MGFs, however, the cellular and molecular mechanisms involved in the dependence of innerva-tion during regeneration are still largely unknown, due to limitations to molecular and genetic manipulation(More)
  • 1